|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.2 CNY | -3.86% |
|
-2.11% | -24.06% |
Pulike Biological Engineering, Inc. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 928.54 million compared to CNY 827.23 million a year ago. Net income was CNY 179.11 million compared to CNY 128.14 million a year ago.
Basic earnings per share from continuing operations was CNY 0.52 compared to CNY 0.41 a year ago. Diluted earnings per share from continuing operations was CNY 0.52 compared to CNY 0.41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.06% | 805M | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -28.16% | 1.2B | |
| -14.67% | 1.12B | |
| -5.37% | 990M |
PULIKE BIOLOGICAL ENGINEERING, INC. 
